How practical are recommendations for dietary control in phenylketonuria?
about
Nutritional Management of PhenylketonuriaPhenylketonuria: a review of current and future treatmentsWhen should social service referral be considered in phenylketonuria?Tetrahydrobiopterin responsiveness in a series of 53 cases of phenylketonuria and hyperphenylalaninemia in IranInfluence of PAH Genotype on Sapropterin Response in PKU: Results of a Single-Center Cohort Study.Phenylalanine hydroxylase deficiency.Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria.Determination of free amino acids in African gourd seed milks by capillary electrophoresis with light-emitting diode induced fluorescence and laser-induced fluorescence detection."MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trialEvaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trialDevelopment and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria - quality of life (PKU-QOL) questionnaires.Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuriaFormulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuriaSapropterin hydrochloride: enzyme enhancement therapy for phenylketonuria.Cardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influencesPhenylketonuria (PKU): A problem solved?Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria.Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype.Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuriaWhole body composition analysis by the BodPod air-displacement plethysmography method in children with phenylketonuria shows a higher body fat percentage.Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acidsDevelopment of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaireNeuroradiological findings of an adolescent with early treated phenylketonuria: is phenylalanine restriction enough?Oxidative stress in phenylketonuria: future directions.Adherence issues in inherited metabolic disorders treated by low natural protein diets.Antioxidant treatment strategies for hyperphenylalaninemia.The neuropsychiatry of inborn errors of metabolism.Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.Molecular genetics and diagnosis of phenylketonuria: state of the art.Clinical therapeutics for phenylketonuria.Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research?Predictability and inconsistencies in the cognitive outcome of early treated PKU patients.Nutrition education tools used in phenylketonuria: clinician, parent and patient perspectives from three international surveys.Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.
P2860
Q24613843-A0DE8279-A613-4FB3-AA9A-426E9696DB2BQ26770291-9A34AC9A-862B-446C-BDF4-754E3C8E39EAQ33799097-41A710F8-0B99-42E1-A33F-3325D38DC617Q33799109-B8C6E994-106C-41A6-A711-F540B915E7CAQ33947342-6DBA590A-0079-4A7C-963F-7B88C2F4513EQ34183829-6ED97CCD-7D4A-48F2-81E9-8CA0DE608DC4Q34325086-7FB69139-6C59-4F1C-B059-996662762F26Q34428243-D3D84AB7-9858-4075-AD17-AFF52EEF8026Q34694827-8EA94E51-2E9C-46E8-A215-E23E4DADCD2AQ34822342-9DA7C3D9-1DE3-4764-9EF3-A0424F86269FQ35097062-85FA5179-8D6F-4E1B-A797-F76ABDDA7D29Q35490408-C2EE5045-AA43-495F-98B3-8B368064E9F1Q35660020-398F9C86-9A03-4FBC-9CC8-8952ADDD8C78Q35666961-F2D6971D-0728-4E34-820C-3594C8EDFD05Q35900593-2524E1AF-5161-4584-8F49-7FE43A1D058CQ35972805-472C638B-9927-40C5-9308-46F72B3CBC59Q36110718-1274DE59-362E-4D7D-841B-DD41B14FA9C2Q36304253-E87DCA34-33E7-4B26-9842-D001F4153B22Q36328025-871D872B-4904-4A94-A766-8E0ECE04FC4AQ36417290-B99202EE-7798-4532-BE67-692300471736Q36680623-D654BB6A-35F4-4717-853A-47F694691EFAQ36680654-2256E23E-37DB-4AC5-9337-2D92B2D9A906Q37014366-51880A98-C17D-4479-BB2C-A0CC4181D40DQ37081629-2489D4A7-572E-447D-8DEA-C9C5BB31A80FQ37132300-EE0FB298-D727-43F9-8340-83760B933450Q37426648-BBCC0CE2-D1FD-475B-A6AA-5015F34D40BBQ37575323-A1796A8A-931B-4E86-A648-5542F9A98F79Q37690085-02BE1590-AFB6-4B4F-B338-4F4316C8BBB2Q37694181-D62C2083-6FD9-43EC-8938-E61BEF4C0B73Q37960805-C4311965-BB57-47C6-B18F-E136012246F8Q38064765-21D705F0-8E53-4E7C-AF21-65F8B698178AQ38105266-7CD900FF-CA7C-4AD9-AB51-2968D84C9EEAQ38108763-716F12A3-1210-44A8-BC72-D70747487438Q38109232-04DDC898-18CE-4305-A8AE-51380DEB4E05Q38216515-0015A6EB-F368-484C-A3A6-5132366FBCE3Q38383086-6459F361-E39A-482F-BA64-22AA11581A68Q38390841-76CC1773-1918-42CE-ABBD-B59406145F08Q38610970-2243CBCE-88FE-4DE6-8013-B5E69B9E0022Q39431877-08017D56-9905-4C62-8153-A32EEF277E9EQ41547697-32388003-63AB-4317-84F8-E497F834090D
P2860
How practical are recommendations for dietary control in phenylketonuria?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
How practical are recommendations for dietary control in phenylketonuria?
@en
How practical are recommendations for dietary control in phenylketonuria?
@nl
type
label
How practical are recommendations for dietary control in phenylketonuria?
@en
How practical are recommendations for dietary control in phenylketonuria?
@nl
prefLabel
How practical are recommendations for dietary control in phenylketonuria?
@en
How practical are recommendations for dietary control in phenylketonuria?
@nl
P2093
P1433
P1476
How practical are recommendations for dietary control in phenylketonuria?
@en
P2093
A MacDonald
D E Francis
G J Shortland
J H Walter
P356
10.1016/S0140-6736(02)09334-0
P407
P577
2002-07-01T00:00:00Z